Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eulexin is FDA-approved for new indication

June 28, 1996

More antitumor taxoids

June 28, 1996

LHRH antagonists from TAP Holdings

June 28, 1996

Antitumor taxoids revealed

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

SKI-2054R synthesized by Sunkyong

June 28, 1996

Agouron and Roche sign codevelopment agreement

June 28, 1996

Lu-Tex deemed safe and effective in phase I trial

June 21, 1996

TH-9402 covered under U.S. patent

June 21, 1996

Encouraging preclinical results for G-3139

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...